India’s first CRISPR Covid-19 test, developed by the Tata Group and CSIR-IGIB, approved for use in India
News: The Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) test, powered by CSIR-IGIB (Institute of Genomics and Integrative Biology) FELUDA, received regulatory approvals from the Drug Controller General of …
Read More